The global recombinant human growth hormone (RHGH) market was valued at approximately USD 1.77 billion in 2024 and is projected to reach around USD 3.89 billion by 2032, representing a strong CAGR of about 10.30% over the forecast period. As treatments for growth hormone deficiency, Turner Syndrome, idiopathic short stature and other indications evolve, recombinant GH therapies are... https://www.databridgemarketresearch.com/reports/global-recombinant-human-growth-hormone-rhgh-market